Rocket Lab Corporation (RKLB)

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 97.27 (as of 2026-06-29)

The panel admires the business and fears the price — almost unanimously. Rocket Lab is a genuine pure-play space-economy company: record Q1 revenue of ~$200M (+63% YoY), a $2.2B backlog that roughly doubled year-over-year, the world's second-most-active launch provider, and a vertically-integrated launch-plus-space-systems model. But at ~$97 after a ~45% pullback from the early-2026 high near $150, it still trades around 45x trailing sales, burns cash, and is funding itself through dilution — and the entire growth thesis rests on Neutron, a medium-lift rocket that has not yet flown (first flight targeted Q4 2026, after a propellant-tank test setback). The growth and momentum frameworks see the most compelling public way to own the space economy; four valuation frameworks place fair value far below the price, with even the bullish fundamental read conceding no margin of safety. With the dominant objection being price rather than the business, a dated binary catalyst pending, and the chart still in a downtrend, the synthesis is WAIT.

Key levels

Key resistance starts at the ~$102 round-number shelf, then the ~$116 falling intermediate-trend zone, up to the ~$149 all-time-high band where the long-term trend signal flipped negative. Key support sits at ~$90 (the recent bounce base), then the ~$80 swing low, with a deeper historical accumulation zone near $57 (the 2024–25 breakout shelf). The analyst consensus target spans roughly USD 75 to 135, averaging near USD 105 — only modestly above the current price — while the panel's own valuation estimates run from the high-$30s to the low $20s, the source of the tension.

What legendary investors think

We ran Rocket Lab past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

Common ground

• The operating momentum is real: record revenue, a backlog that doubled year-over-year, Electron at the world's #2 launch cadence, and improving gross margins (~38–43%).
• The business is still pre-profit and cash-consuming (~$77M Q1 operating burn), funded by a large equity raise that adds ~25% dilution — runway, but at shareholders' expense.
• Neutron is the swing factor: a successful Q4 2026 first flight is a major catalyst; a delay extends the loss period. Even the CEO frames it as "mission enabling, not mission critical."
• At ~45–90x sales (depending on the basis), there is no margin of safety on any earnings-based measure — the bulls and bears agree on this, and disagree only on whether the story justifies it.

The real debate

• Platform or price? The Disruptive-Innovation Seeker sees a vertically-integrated space platform with a multi-year runway; the valuation and value frameworks see a faith-based bet priced for flawless execution.
• Is Neutron an option or the whole thesis? Bulls treat Electron + Space Systems as a growing base with Neutron as upside; the skeptics note ~$52B+ of market value already assumes Neutron flies and wins share against SpaceX.
• Froth deflating or correcting? The momentum lens reads the ~45% drawdown plus a 18.5%-short-interest setup as squeeze fuel; the Forensic Skeptic reads it as a speculative name still searching for its floor.

The question it comes down to: Is ~$97 a fair price to pre-pay for a vertically-integrated space platform whose Neutron rocket will open a far larger market — or is it 2–4x what the proven Electron/Space Systems business is worth, with the difference resting on a rocket that has not yet left the pad?

The numbers

Metric	Value
Price / Market cap	USD 97.27 / ~61B
P/E (TTM / fwd)	n/a (pre-profit); P/S ~45x TTM
ROE	n/a (net loss)
Operating margin	~ -22% (GAAP net margin, Q1 2026)
Dividend yield	0% (no dividend)
Debt / equity	~0.2x
Free cash flow	~ -USD 300M (annualized cash burn; ~-$77M Q1 2026)

Figures as of Q1 2026 / June 2026; sourced from Rocket Lab IR/SEC 8-K, StockAnalysis, GuruFocus, MacroTrends, MarketBeat. Rocket Lab is pre-profit, so no P/E or ROE applies; valuation rests on price-to-sales and scenario analysis of a future Neutron ramp. P/S estimates vary widely by source (~45x TTM to ~88x EV/revenue) depending on the revenue and share-count basis used.

The bottom line

Rocket Lab is the rare case where almost every framework on the panel likes the company and balks at the quote. The bull case is concrete and improving: a doubling backlog, accelerating revenue, the world's second-busiest launch cadence, expanding margins, and a Neutron rocket that — if it flies — opens a vastly larger market than Electron's small-satellite niche, all wrapped in the only vertically-integrated pure-play public space platform. The caution is equally concrete and, unusually, shared even by the bulls: at roughly 45–90x sales the stock prices a fully-realized Neutron success today, the company still burns ~$77M a quarter and dilutes ~25% a year to fund itself, Neutron has already slipped on a test failure, and four independent valuation frameworks place fair value somewhere between the high-$30s and low-$20s — well below the $97 price. What would tip the synthesis bullish is execution that converts the story into proof: a successful Neutron first flight, continued backlog conversion, and a credible line of sight to positive free cash flow. What would keep it cautious is the opposite — a Neutron delay, a revenue miss against the $225–240M Q2 guide, or further dilution — against a chart still in a downtrend below its key intermediate levels. With the objection centered on price rather than the business and a dated, binary catalyst still ahead, the panel's weight rests on patience.